EDE.ASX: Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly Activities/Appendix 4C Cash Flow Report

Stock	Eden Innovations Ltd (EDE.ASX)
Release Time	31 Jul 2026, 9:41 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Eden Innovations Ltd Reports Strong Trial Results and Expansion

Key Points

Strong EdenCrete® trial results and regional expansion
New appointments to drive EdenShield® growth in Australia and Europe
US$2.90 million of OptiBlend® quotations issued during FY26
Completed $4.05 million placement and achieved debt-free status

Full Summary

Eden Innovations Ltd (ASX:EDE) reported significant progress in the quarter ended 30 June 2026, highlighted by strong trial results for its EdenCrete® product, particularly EdenCrete® Pz7, which saw exponential growth in installations. The company expanded its presence in the US and India, with positive trial results in Delhi indicating potential for large-scale adoption. Additionally, key appointments were made to drive the growth of EdenShield®, Eden's defense and infrastructure division. The company also reported US$2.90 million in OptiBlend® quotations issued during FY26, reflecting growing demand from US data center operators. A $4.05 million placement was completed, and the company achieved debt-free status by settling remaining loans and director fees.

Outlook

Eden enters FY2027 well-funded, with $5.2 million cash at bank, to accelerate commercialisation of EdenCrete®, OptiBlend® and EdenShield® technology lines.